Andra AP fonden Acquires Shares of 210,900 Kenvue Inc. $KVUE

Key Points

• Andra AP fonden acquired 210,900 Kenvue shares worth approximately $4.03 million in the second quarter. Institutional investors own 97.64% of the company, with several funds increasing their positions.
• Analyst sentiment remains cautious: Kenvue has a consensus “Hold” rating and an average price target of $19.27, while recent targets range from $19 to $20.
• Kenvue reported quarterly revenue of $3.96 billion, up 3% year over year, but narrowly missed earnings estimates. The company announced a quarterly dividend of $0.21, equivalent to a 4.8% annualized yield.

Andra AP fonden purchased a new position in shares of Kenvue Inc. (NYSE:KVUE - Free Report) during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 210,900 shares of the company's stock, valued at approximately $4,030,000.

A number of other institutional investors have also added to or reduced their stakes in KVUE. HBK Investments L P boosted its stake in shares of Kenvue by 33.3% in the 2nd quarter. HBK Investments L P now owns 28,000,001 shares of the company's stock worth $535,080,000 after buying an additional 7,000,000 shares during the last quarter. Core Capital Management & Research inc. purchased a new stake in shares of Kenvue during the 2nd quarter valued at $240,000. Tidal Investments LLC raised its stake in shares of Kenvue by 14.0% during the 2nd quarter. Tidal Investments LLC now owns 549,380 shares of the company's stock worth $10,499,000 after purchasing an additional 67,537 shares during the period. National Pension Service raised its stake in shares of Kenvue by 10.2% during the 2nd quarter. National Pension Service now owns 3,369,149 shares of the company's stock worth $64,384,000 after purchasing an additional 310,824 shares during the period. Finally, WINTON GROUP Ltd boosted its holdings in shares of Kenvue by 196.9% in the 2nd quarter. WINTON GROUP Ltd now owns 49,165 shares of the company's stock worth $940,000 after buying an additional 32,605 shares during the last quarter. 97.64% of the stock is owned by institutional investors.

Analysts Set New Price Targets

KVUE has been the subject of a number of research analyst reports. Zacks Research downgraded shares of Kenvue from a "strong-buy" rating to a "hold" rating in a report on Tuesday, July 7th. Wall Street Zen downgraded shares of Kenvue from a "buy" rating to a "hold" rating in a research report on Saturday, August 8th. Barclays upped their price objective on Kenvue from $18.00 to $19.00 and gave the company an "equal weight" rating in a research note on Tuesday, July 21st. UBS Group reduced their price objective on Kenvue from $20.00 to $19.00 and set a "neutral" rating for the company in a report on Tuesday, August 11th. Finally, Weiss Ratings restated a "hold (c)" rating on shares of Kenvue in a research note on Friday, September 11th. Three research analysts have rated the stock with a Buy rating and eleven have issued a Hold rating to the company's stock. According to data from MarketBeat, the company has a consensus rating of "Hold" and a consensus price target of $19.27.

Kenvue Stock Down 1.0%

KVUE stock opened at $17.68 on Thursday. The company's 50 day moving average is $18.82 and its 200 day moving average is $18.19. The stock has a market cap of $33.95 billion, a price-to-earnings ratio of 20.32, a price-to-earnings-growth ratio of 1.64 and a beta of 0.46. The company has a current ratio of 1.01, a quick ratio of 0.71 and a debt-to-equity ratio of 0.67. Kenvue Inc. has a 1-year low of $14.02 and a 1-year high of $20.13.

Kenvue (NYSE:KVUE - Get Free Report) last released its earnings results on Thursday, August 6th. The company reported $0.31 earnings per share for the quarter, missing analysts' consensus estimates of $0.32 by ($0.01). Kenvue had a return on equity of 21.22% and a net margin of 10.76%.The firm had revenue of $3.96 billion during the quarter, compared to the consensus estimate of $3.97 billion. During the same quarter in the previous year, the firm earned $0.29 EPS. The business's quarterly revenue was up 3.0% compared to the same quarter last year. Sell-side analysts predict that Kenvue Inc. will post 1.14 EPS for the current fiscal year.

Kenvue Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, October 2nd. Stockholders of record on Monday, September 21st will be given a $0.21 dividend. This represents a $0.84 annualized dividend and a dividend yield of 4.8%. The ex-dividend date of this dividend is Monday, September 21st. Kenvue's dividend payout ratio (DPR) is currently 96.55%.

Kenvue Company Profile

Kenvue Inc is a global consumer health company that develops, markets and sells products designed to support everyday health and personal care. Its portfolio spans over-the-counter medicines, skin health and beauty, essential health products, and baby and family care.

The company's brands include Tylenol, Motrin, Zyrtec and Benadryl in self-care; Neutrogena, Aveeno and Clean & Clear in skin health and beauty; Listerine in oral care; and Johnson's and Band-Aid in baby care and essential health.

Want to see what other hedge funds are holding KVUE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Kenvue Inc. (NYSE:KVUE - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.